First Bellwether Trials Scheduled In the MDL For Pradaxa Cases

The first bellwether trials in the MDL for Pradaxa cases have been scheduled to begin in August 2014. The drug has been under attack by physicians groups and patient advocates since 3,781 adverse effects and 542 deaths associated with Pradaxa were reported last year to the Food and Drug Administration.

Its adverse reports and deaths surpassed all other monitored drugs. The FDA is now conducting a safety review of the drug, which millions of people around the country take twice a day. If you or loved one has suffered internal bleeding or other serious injury while taking Pradaxa, call our attorneys today at 860-667-0839.